FDA Safety Information and Adverse Event Reporting
Methotrexate Sodium, USP Injectable Vials by Sandoz US: Recall - Particulate Matter In Vials
Abbott Diabetes Care: Class 1 Recall - FreeStyle InsuLinx Blood Glucose Meters - Risk of Incorrect Test Result
All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance
Compounded Prescription Therapies By Pentec Health Inc.: Recall - Lack Of Sterility Assurance
Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses
Atriphen dietary supplement (Xymogen brand): Recall - Potential Allergic Reaction Due to Milk and Soy
The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products
SexVoltz, Velextra, and Amerect by Beomonstar Products: Recall - Undeclared Drug Ingredient
Bullet Proof: Public Notification - Undeclared Drug Ingredient
Lightning Rod Capsules: Recall - Undeclared Drug Ingredient
Maquet SERVO-i Ventilator Battery Module: Class 1 Recall - Battery Run Time Shorter Than Expected
Medtronic: Class 1 Recall - Medtronic Deep Brain Stimulation Lead Kit and Activa Dystonia HDE Kit
Covidien Surgical Stapler Reloads: FDA Safety Communication - Devices Stolen Before They Were Sterilized
Cardinal Health: Class 1 Recall - Various Presource Kits Containing a Pre-Assembled Anesthesia Circuit
Valproate Anti-Seizure Products: Drug Safety Communication - Contraindicated for Pregnant Women for Prevention of Migraine Headaches
Kadcyla (ado-trastuzumab emtansine): Drug Safety Communication - Potential Medication Errors Resulting from Name Confusion
American Lifestyle Vicerex and Black Ant Capsules: Recall - Undeclared Drug Ingredient
Hospira Inc., GemStar Infusion System: Recall - Lithium Battery Low Voltage
Newport Medical Instruments, Inc., HT70 and HT70 Plus Ventilators: Class I Recall - Unit Goes Into Internal Backup Battery Sooner Than Expected
Anticoagulant Citrate Phosphate Dextrose Solution, USP (CPD) BLOOD-PACK Unit By Fenwal: Recall - Labeling Issue Identified

FDA Safety Information and Adverse Event Reporting

Description

May 20, 2013
Incorrect test results at extremely high blood glucose levels.
Web Link

FDA Safety Information and Adverse Event Reporting is a sample topic found in Davis's Drug Guide.

To find other Davis's Drug Guide topics please log in or purchase a subscription.

Content Manager